Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus
ZL Sun, SC Sun, JM He, JE Lan, S Gibbons… - International journal of …, 2020 - Elsevier
Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), remains a
challenge in hospital and community settings. The design and discovery of new compounds …
challenge in hospital and community settings. The design and discovery of new compounds …
[PDF][PDF] Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus
ZL Sun, SC Sun, JM He, JE Lan, S Gibbons, Q Mu - research-portal.uea.ac.uk
Staphylococcus aureus including methicillin resistant variants (MRSA) is still a challeng in
the clinical and community settings. The design and discovery of new compounds to deal …
the clinical and community settings. The design and discovery of new compounds to deal …
Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus
ZL Sun, SC Sun, JM He, JE Lan… - International journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), remains a
challenge in hospital and community settings. The design and discovery of new compounds …
challenge in hospital and community settings. The design and discovery of new compounds …
Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus.
ZL Sun, SC Sun, JM He, JE Lan, S Gibbons, Q Mu - 2020 - cabidigitallibrary.org
Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), remains a
challenge in hospital and community settings. The design and discovery of new compounds …
challenge in hospital and community settings. The design and discovery of new compounds …
Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus
ZL Sun, SC Sun, JM He, JE Lan… - International Journal …, 2020 - ueaeprints.uea.ac.uk
Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), remains a
challenge in hospital and community settings. The design and discovery of new compounds …
challenge in hospital and community settings. The design and discovery of new compounds …
Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus.
ZL Sun, SC Sun, JM He, JE Lan… - International Journal of …, 2020 - europepmc.org
Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), remains a
challenge in hospital and community settings. The design and discovery of new compounds …
challenge in hospital and community settings. The design and discovery of new compounds …
[PDF][PDF] Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus
ZL Sun, SC Sun, JM He, JE Lan, S Gibbons, Q Mu - ueaeprints.uea.ac.uk
Staphylococcus aureus including methicillin resistant variants (MRSA) is still a challeng in
the clinical and community settings. The design and discovery of new compounds to deal …
the clinical and community settings. The design and discovery of new compounds to deal …
Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus
ZL Sun, SC Sun, JM He, JE Lan… - International …, 2020 - research-portal.uea.ac.uk
Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), remains a
challenge in hospital and community settings. The design and discovery of new compounds …
challenge in hospital and community settings. The design and discovery of new compounds …